Skip to main content
Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,209
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,841
Class I recallsReasonable probability of serious health consequences
24,366
Class II recallsTemporary or medically reversible health consequences
2,892
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,073 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/frutas-y-hortalizas-del-sur-sa-expands-recalls-include-additional-lots-great-value-frozen-organicPublished October 2, 2026
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,714 recalls have been announced year to date.
  • Sep 2026 was 3% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (297).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,366
Class I9,841
Class III2,892
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,366
Class I9,841
Class III2,892
Not Yet Classified2

Showing 15,321–15,340 of 21,652 recalls

FDA Recall United States Terminated Historical recordClass I

Biery Cheese, Inc.

Product
FINLANDIA SRIRACHA JACK & JALAPENO JACK CHEESE NET WT. 12 O…
Reason
The firm was notified by their supplier that various cheese products test positive for Listeria monocytogenes.
Published
April 12, 2017
Distribution
Product was shipped to the following sta…

View recall →

FDA Recall United States Terminated Historical recordClass I

Biery Cheese, Inc.

Product
DIETZ & WATSON Pepper Jack Cheese NET WT. 8 OZ. (227G) INGR…
Reason
The firm was notified by their supplier that various cheese products test positive for Listeria monocytogenes.
Published
April 12, 2017
Distribution
Product was shipped to the following sta…

View recall →

FDA Recall United States Terminated Historical recordClass I

Biery Cheese, Inc.

Product
DIETZ & WATSON Pasteurized Process New York State Cheddar C…
Reason
The firm was notified by their supplier that various cheese products test positive for Listeria monocytogenes.
Published
April 12, 2017
Distribution
Product was shipped to the following sta…

View recall →

FDA Recall United States Terminated Historical recordClass I

Biery Cheese, Inc.

Product
DELALLO Premium Sliced HOT PEPPER CHEESE NET WT. 8 OZ. (227G…
Reason
The firm was notified by their supplier that various cheese products test positive for Listeria monocytogenes.
Published
April 12, 2017
Distribution
Product was shipped to the following sta…

View recall →

FDA Recall United States Terminated Historical recordClass I

Biery Cheese, Inc.

Product
DELALLO Premium Sliced COLBY CHEESE NET WT. 8 OZ. (227G) ING…
Reason
The firm was notified by their supplier that various cheese products test positive for Listeria monocytogenes.
Published
April 12, 2017
Distribution
Product was shipped to the following sta…

View recall →

FDA Recall Terminated Historical recordClass III

Montelukast sodium tablets, 10 mg, 30-count bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: HETERO Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, NDC 31722-726-30

by Hetero USA Inc

Reason
Discoloration: the firm received a complaint of a sealed bottle in which tablets inside had blue spots and a blue powder inside the bottle.
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Metronidazole Injection, USP, 500 mg/100 mL, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-001-24

by Claris Lifesciences Inc

Reason
Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ciprofloxacin in Dextrose (5%) Injection, USP, 400 mg in 200 mL 5% Dextrose, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-009-24

by Claris Lifesciences Inc

Reason
Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Sensodyne Repair & Protect Whitening, (stannous fluoride 0.45% (0.15% w/v fluoride ion)), Net Wt. 3.4 oz, Distributed by Glaxo SmithKline Consumer Healthcare LP Moon Township PA 15108 --- NDC 0135-0575-01, UPC UPC: 3 10158 84060 2

by GSK Consumer Healthcare

Reason
Presence of Foreign Substance; low concentration of an additional flavoring ingredient, Patchouli oil resulting in complaints of off flavor/scent
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Atorvastatin Calcium Tablets, 10 mg*, 100-count Unit Dose Tablets (10 x 10) per carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.., NDC 51079-208-20

by Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Reason
Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Atorvastatin Calcium Tablets, 80 mg*, packaged in a) 90-count bottles (NDC 0378-3953-09) and b) 500-count bottles (NDC 0378-3953-07), Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.

by Mylan Pharmaceuticals Inc.

Reason
Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Atorvastatin Calcium Tablets, 40 mg*, packaged in a) 90-count bottles (NDC 0378-3952-09) and b) 500-count bottles (NDC 0378-3952-07); Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.

by Mylan Pharmaceuticals Inc.

Reason
Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Atorvastatin Calcium Tablets, 20 mg*, packaged in a) 90-count bottles (NDC 0378-3951-09) and b) 500-count bottles (NDC 0378-3951-07); Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.

by Mylan Pharmaceuticals Inc.

Reason
Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Atorvastatin Calcium Tablets, 10 mg*, packaged in a) 90-count bottles (NDC 0378-3950-77); b) 90-count bottles (NDC 0378-3950-09); c) 500-count bottles (NDC 0378-3950-05); d) 500-count bottles (NDC 0378-3950-07), Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.

by Mylan Pharmaceuticals Inc.

Reason
Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Divalproex Sodium Delayed Release Tablets, USP, 500 mg, a) 100 count (NDC 68382-033-01) and b) 500 count (NDC 68382-033-05) bottles, Rx only, manufactured by Cadila Healthcare Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals, Pennington, NJ

by Zydus Pharmaceuticals USA Inc

Reason
Failed Dissolution Specifications; 9 month long term stability
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Levofloxacin Injection in 5% Dextrose, 750 mg in 150 mL 5% Dextrose, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-048-24

by Claris Lifesciences Inc

Reason
Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Fluconazole Injection, USP, 400 mg in 200 mL, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-003-06

by Claris Lifesciences Inc

Reason
Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.
Published
April 5, 2017
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

Butala Emporium, Inc.

Product
Baidyanath brand Chitrakadi Bati, Dietary Supplement, 80 Ta…
Reason
The dietary supplements were found to contain lead, mercury and/or arsenic at levels exceeding permissible limits.
Published
April 5, 2017
Distribution
NY (via 3 retail stores) and directly to…

View recall →

FDA Recall United States Terminated Historical recordClass I

Butala Emporium, Inc.

Product
Baidyanath brand Gaisantak Bati, Dietary Supplement, 80 Tab…
Reason
The dietary supplements were found to contain lead, mercury and/or arsenic at levels exceeding permissible limits.
Published
April 5, 2017
Distribution
NY (via 3 retail stores) and directly to…

View recall →

FDA Recall United States Terminated Historical recordClass I

Butala Emporium, Inc.

Product
Baidyanath brand Brahmi Bati, Dietary Supplement, 80 Tablet…
Reason
The dietary supplements were found to contain lead, mercury and/or arsenic at levels exceeding permissible limits.
Published
April 5, 2017
Distribution
NY (via 3 retail stores) and directly to…

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.